The update comes almost a month after the first human case was reported. The brain chip is designed to help people with spinal cord injuries.
“Progress is good, [and the] patient seems to have made a full recovery … and is able to control the mouse, move the mouse around the screen just by thinking,” Elon Musk, owner of Neuralink, said in an X Spaces event.
The implant got FDA approval for human trials in May, and recruitment for human trials began in September.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
